Bioprocess Online

"Why'd you launch a biotech?" I've asked the question hundreds of times, received dozens of interesting answers. None has been as direct and powerful as the one I heard from OS Therapies Chair and CEO Paul Romness. Tune in to the #businessofbiotech on 11/4, anywhere you listen to #podcasts, for the full story. Or catch up on the latest episodes here: https://lnkd.in/ec58V3sw #osteocarcoma #antibodydrugconjugates

🔬"Bioprocess Pulse" October 2024 Review! 📅 Your monthly guide to the latest from Bioprocess Online. Recap top content from last month and preview upcoming webinars and events. Stay informed effortlessly! #BioprocessPulse #UpcomingEvents

Read about my conversation with Coya Therapeutics, Inc. executive chairman, Howard Berman, Ph.D., where he explains the company's multi-targeted approach to treating neurodegenerative diseases. https://lnkd.in/edAinE9P

🔬 **Webinar Invitation: Advancing Cancer Therapeutics with Novel ADC Payloads** 🔬 Antibody-drug conjugates (ADC) represent a promising frontier in cancer treatment, offering targeted efficacy with minimal adverse effects. Yet, access to optimal ADC payloads remains a hurdle. Join Samsung Biologics as we introduce two innovative payloads—derivatives of camptothecin and duocarmycin—designed for safety and potent efficacy. 📅 **Date:** November 6   🕙 **Time:** [11 AM (ET) 5AM (CET) **What You’ll Learn:** ✨ Key factors in selecting high-quality payloads for ADC drug development   🔬 Insights into the physicochemical and biological performance of our novel payloads   💡 How to easily evaluate these payloads for your ADC antibodies through our ‘Easy to Access Technology program’ Don't miss this opportunity to explore game-changing ADC advancements without financial or technical barriers! https://lnkd.in/eRzGUR3q

These things are NOT supplier quality agreements. ❌Master service agreement. ❌Confidentiality agreement. ❌A governing document for liability or delivery terms. An SQA follows contract or MSA signing. At a high level, here's what it does: ✔️ Establish the scope, definitions and processes for GMP manufacturing. ✔️ Describe procedures for conflict resolution. ✔️ Establish a protocol for updating documents, including itself. As usual, Alexander Aust, MS, MBA brings highly practical advice for crafting SQAs, including a downloadable 12-page responsibility matrix for splitting up duties, per #FDA recommendation.

Webinar Invitation: Advancing Cancer Therapeutics with Novel ADC Payloads Antibody-drug conjugates (ADC) represent a promising frontier in cancer treatment, offering targeted efficacy with minimal adverse effects. Yet, access to optimal ADC payloads remains a hurdle. Join Samsung Biologics as we introduce two innovative payloads—derivatives of camptothecin and duocarmycin—designed for safety and potent efficacy. 📅 **November 7   🕙 **11:00AM  REGISTER: https://lnkd.in/ezV4Dv6H **What You’ll Learn:** ✨ Key factors in selecting high-quality payloads for ADC drug development   🔬 Insights into the physicochemical and biological performance of our novel payloads   💡 How to easily evaluate these payloads for your ADC antibodies through our ‘Easy to Access Technology program’ Don't miss this opportunity to explore game-changing ADC advancements without financial or technical barriers!

Join us Friday November 1, 2024 at 11am EDT for the webinar, to discover how to transform data into achievable insights for optimizing your cell culture process" "Analytical Solutions To Help Accelerate Bioprocessing Success" Key topics include: *Performance Optimization *Metabolite & Lipid Analysis *Customized Analytics *Prototyping for CGMP Register here for free: https://lnkd.in/d_TdSRa9 #cellculture #Bioprocessing #performanceoptimization #lifesciences

🌟 **Enhancing Monoclonal Antibody Production: The Role of Peptones in Boosting Quality and Yield** 🌟 Join us for a webinar exploring the transformative role of peptones in CHO bioprocessing to improve productivity, quality, and yield across multiple cell lines! Our session will cover: 📈 Insights on increasing productivity across various CHO cell lines   📊 Real-world data on peptone effects on titer, protein quality, and cell growth   🔍 Strategies for managing peptone variability to achieve bioprocess consistency  📅 **Date:** Monday, November 4, 2024   🕚 **Time:** 11:00 AM EST  Don't miss this opportunity to deepen your knowledge in CHO bioprocess optimization! https://lnkd.in/eQJYajfa

A Comprehensive Guide For Supplier Quality Agreements https://lnkd.in/e5RxFBaG An SQA is a written agreement that is mutually approved by the biopharma company and the supplier establishing cGMP responsibilities that each group is specifically responsible for.

For over 10 years, #downstream #bioprocessing (DSP) capacity has been considered an Achilles' heel of biomanufacturing, with #purification and separation steps notoriously slowing production. According to the 21st Annual Survey of Biopharmaceutical Manufacturing Capacity and Production, these challenges began as #upstream titers coming from bioreactors were increasing and productivity was improving. Downstream innovations were slower to keep up.  Continue on to read this article : Survey Says Downstream Biomanufacturing Bottleneck Is Over: https://lnkd.in/gNtie8dE #biomanufacturing #downstreamprocessing #biopharma #innovation